The Newly Synthesized Pyrazole Derivative 5-(1-(3 Fluorophenyl)-1-Pyrazol-4-yl)-2-Tetrazole Reduces Blood Pressure of Spontaneously Hypertensive Rats NO/cGMO Pathway

about

The Newly Synthesized Pyrazole Derivative 5-(1-(3 Fluorophenyl)-1-Pyrazol-4-yl)-2-Tetrazole Reduces Blood Pressure of Spontaneously Hypertensive Rats NO/cGMO Pathway

Item

http://www.wikidata.org/entity/Q58797147

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The Newly Synthesized Pyrazole Derivative 5-

@nl

The Newly Synthesized Pyrazole ...... ertensive Rats NO/cGMO Pathway

@en

type

Item

label

The Newly Synthesized Pyrazole Derivative 5-

@nl

The Newly Synthesized Pyrazole ...... ertensive Rats NO/cGMO Pathway

@en

prefLabel

The Newly Synthesized Pyrazole Derivative 5-

@nl

The Newly Synthesized Pyrazole ...... ertensive Rats NO/cGMO Pathway

@en

P1476

The Newly Synthesized Pyrazole ...... ertensive Rats NO/cGMO Pathway

@en

P2093

Ana C S Rebelo

http://www.w3.org/2001/XMLSchema#string

Carlos H Castro

http://www.w3.org/2001/XMLSchema#string

Gustavo R Pedrino

http://www.w3.org/2001/XMLSchema#string

James O Fajemiroye

http://www.w3.org/2001/XMLSchema#string

Lara M Naves

http://www.w3.org/2001/XMLSchema#string

Luciano M Lião

http://www.w3.org/2001/XMLSchema#string

Nathalia O Amaral

http://www.w3.org/2001/XMLSchema#string

Neidiane R Trindade

http://www.w3.org/2001/XMLSchema#string

Paulo R Lopes

http://www.w3.org/2001/XMLSchema#string

Pedro H Alves

http://www.w3.org/2001/XMLSchema#string

P2860

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway.

Presynaptic regulation of neurotransmitter release in hypertension.

Kidney in hypertension: guyton redux.

P304

1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2018.01073

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30131720

http://www.w3.org/2001/XMLSchema#string

P932

6091002

http://www.w3.org/2001/XMLSchema#string